Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma

Table 1 Correlation between survivin expression and clinicopathology in HCC n (%)

Clinicopathological factor		n	Survivin expression		P value
			positive	negative
Sex	Male	41	23	6	0.392
	Female	14	6	8
Age (yr)	≤ 55	40	22	18	0.581
	> 55	15	7	8
Tumor site	Right lobe	30	14	16	0.615
	Left lobe	20	12	8
	Whole liver	5	3	2
HBsAg	Positive	42	21	21	0.467
	Negative	13	8	5
Differentiation	Moderate to well	40	23	17	0.247
	Poor	15	6	9
Intrahepatic metastatic nodes	(+)	21	16	5	0.006
	(–)	34	13	21
Portal vein thrombi	(+)	14	12	2	0.004
	(–)	41	17	24
Tumor capsule	(+)	22	12	10	0.825
	(–)	33	17	16
Tumor size (cm)	≤ 5	16	8	8	0.795
	> 5	39	21	18
AF P(μg/L)	< 400	19	7	12	0.086
	≥ 400	36	22	14
Hepatocirrhosis	(+)	37	21	16	0.391
	(–)	18	8	10
Tumor stage	I-II	27	14	13	0.898
	III-IV	28	15	13